Automating CAR‐T Transfection with Micro and Nano‐Technologies
Source abstract
Abstract
Abstract Cancer poses a significant health challenge, with traditional treatments like surgery, radiotherapy, and chemotherapy often lacking in cell specificity and long‐term curative potential. Chimeric antigen receptor T cell (CAR‐T) therapy,utilizing genetically engineered T cells to target cancer cells, is a promising alternative. However, its high cost limits widespread application. CAR‐T manufacturing process encompasses three stages: cell isolation and activation, transfection, and expansion.While the first and last stages have straightforward, commercially available automation technologies, the transfection stage lags behind. Current automated transfection relies on viral vectors or bulk electroporation, which have drawbacks such as limited cargo capacity and significant cell disturbance. Conversely, micro and nano‐tool methods offer higher throughput and cargo flexibility, yet their automation remains underexplored.In this perspective, the progress in micro and nano‐engineering tools for CAR‐T transfection followed by a discussion to automate them is described. It is anticipated that this work can inspire the community working on micro and nano transfection techniques to examine how their protocols can be automated to align with the growing interest in automating CAR‐T manufacturing.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: CAR-T cell therapy research · Viral Infectious Diseases and Gene Expression in Insects · Microfluidic and Bio-sensing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Engineering Science Programme National University of Singapore Singapore 117575 Singapore
Department of Biomedical Engineering National University of Singapore Singapore 117583 Singapore
Institute for Health Innovation & Technology National University of Singapore Singapore 117599 Singapore
Yong Loo Lin School of Medicine National University of Singapore Singapore 117597 Singapore
Tissue Engineering Programme National University of Singapore Singapore 117510 Singapore
References (100+)
Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. 10.3322/caac.2176310.3322/caac.21763 ↗
3. 10.1002/ijc.3358810.1002/ijc.33588 ↗
4. Chhikara B. S. · Chem. Biol. Lett. · 2023 · 10 · 451
5. Cavalcanti I. D. L. · 2021 · 2910.1007/978-3-030-68334-4_4 ↗
6. 10.1038/nrclinonc.2014.19110.1038/nrclinonc.2014.191 ↗
7. 10.1201/b1775110.1201/b17751 ↗
8. 10.3389/fmolb.2014.0002410.3389/fmolb.2014.00024 ↗
9. 10.4236/jct.2014.5808910.4236/jct.2014.58089 ↗
10. Dennert G. · Cochrane Database Syst. Rev. · 2006
11. 10.1002/jgm.260410.1002/jgm.2604 ↗
12. 10.1093/jnci/djv43910.1093/jnci/djv439 ↗
13. 10.1186/s13045-017-0423-110.1186/s13045-017-0423-1 ↗
14. 10.3390/cancers1503066310.3390/cancers15030663 ↗
15. 10.1126/science.abm059410.1126/science.abm0594 ↗
16. 10.1016/j.cell.2022.10.02610.1016/j.cell.2022.10.026 ↗
17. 10.1038/s41586-020-2403-910.1038/s41586-020-2403-9 ↗
18. 10.1038/s41573-019-0051-210.1038/s41573-019-0051-2 ↗
19. 10.1038/s41467-022-32866-010.1038/s41467-022-32866-0 ↗
20. 10.1016/j.copbio.2018.01.02510.1016/j.copbio.2018.01.025 ↗
21. 10.1038/nri319110.1038/nri3191 ↗
22. 10.1002/adtp.20190013310.1002/adtp.201900133 ↗
23. 10.1021/acsnano.0c0462410.1021/acsnano.0c04624 ↗
24. 10.1038/nature1976410.1038/nature19764 ↗
25. 10.1016/j.sbi.2009.12.00610.1016/j.sbi.2009.12.006 ↗
26. 10.1016/j.lfs.2022.12037510.1016/j.lfs.2022.120375 ↗
27. 10.1089/1043034995001907510.1089/10430349950019075 ↗
28. 10.1038/nrg106610.1038/nrg1066 ↗
29. 10.1038/nnano.2017.13410.1038/nnano.2017.134 ↗
30. 10.1016/j.colsurfb.2004.10.00710.1016/j.colsurfb.2004.10.007 ↗
31. 10.1186/1472-6750-10-910.1186/1472-6750-10-9 ↗
32. 10.1134/S000629790910002210.1134/S0006297909100022 ↗
33. 10.1038/cgt.2014.7810.1038/cgt.2014.78 ↗
34. 10.1016/j.jconrel.2006.04.01410.1016/j.jconrel.2006.04.014 ↗
35. 10.1038/nbt.261210.1038/nbt.2612 ↗
36. 10.1016/S0302-4598(96)05062-310.1016/S0302-4598(96)05062-3 ↗
37. 10.1007/BF0234489210.1007/BF02344892 ↗
38. 10.1002/adma.20200742110.1002/adma.202007421 ↗
39. 10.1002/smll.20100094610.1002/smll.201000946 ↗
40. 10.1038/nature0506410.1038/nature05064 ↗
41. 10.1073/pnas.090935010710.1073/pnas.0909350107 ↗
42. 10.1021/acs.nanolett.7b0195010.1021/acs.nanolett.7b01950 ↗
43. 10.1007/s11899-021-00635-310.1007/s11899-021-00635-3 ↗
44. Grand View Research Allogeneic Cell Therapy Market Size Share & Trends Analysis Report By Therapy Type (Stem Cell Non‐Stem Cell) By Therapeutic Area (Hematological Disorders Dermatological Disorders) By Region And Segment Forecasts 2023 ‐ 2030 2023.
45. 10.1016/j.bej.2022.10876410.1016/j.bej.2022.108764 ↗
46. 10.1007/s10529-019-02732-z10.1007/s10529-019-02732-z ↗
47. 10.1371/journal.pone.025453610.1371/journal.pone.0254536 ↗
48. 10.1021/bp010183910.1021/bp0101839 ↗
49. 10.1016/j.chroma.2021.46191410.1016/j.chroma.2021.461914 ↗
50. 10.1016/j.jcyt.2016.05.00910.1016/j.jcyt.2016.05.009 ↗
51. Abraham E. · 2018 · 323
52. 10.1021/acs.chemrev.7b0067810.1021/acs.chemrev.7b00678 ↗
53. 10.1038/nature0505810.1038/nature05058 ↗
54. 10.1016/j.cobme.2021.10034210.1016/j.cobme.2021.100342 ↗
55. 10.1073/pnas.121870511010.1073/pnas.1218705110 ↗
56. 10.1021/acs.nanolett.8b0070410.1021/acs.nanolett.8b00704 ↗
57. 10.1007/s10544-010-9440-310.1007/s10544-010-9440-3 ↗
58. 10.1007/s10544-010-9507-110.1007/s10544-010-9507-1 ↗
59. 10.1038/s41571-022-00607-310.1038/s41571-022-00607-3 ↗
60. 10.1039/c1lc20766k10.1039/c1lc20766k ↗
61. 10.1073/pnas.77.12.738010.1073/pnas.77.12.7380 ↗
62. 10.1016/j.copbio.2008.07.00510.1016/j.copbio.2008.07.005 ↗
63. 10.1039/b803212b10.1039/b803212b ↗
64. 10.1002/bies.2075910.1002/bies.20759 ↗
65. 10.1371/journal.pone.000086210.1371/journal.pone.0000862 ↗
66. 10.1109/TASE.2022.320815210.1109/TASE.2022.3208152 ↗
67. 10.1056/NEJMoa170986610.1056/NEJMoa1709866 ↗
68. 10.1056/NEJMoa191434710.1056/NEJMoa1914347 ↗
69. 10.1021/acs.nanolett.9b0317510.1021/acs.nanolett.9b03175 ↗
70. 10.1007/BF0069770210.1007/BF00697702 ↗
71. 10.1109/TNB.2008.200074210.1109/TNB.2008.2000742 ↗
72. 10.1002/jbio.20150024010.1002/jbio.201500240 ↗
73. 10.1038/418290a10.1038/418290a ↗
74. 10.1038/srep0655310.1038/srep06553 ↗
75. 10.1039/C3IB40215K10.1039/C3IB40215K ↗
76. 10.1002/admt.20230027510.1002/admt.202300275 ↗
77. 10.1039/c2lc40708f10.1039/c2lc40708f ↗
78. 10.1038/srep1118510.1038/srep11185 ↗
79. 10.1002/jbio.20081001110.1002/jbio.200810011 ↗
80. 10.1021/nl303421h10.1021/nl303421h ↗
81. Sharei A. · J. Vis. Exp. · 2013
82. 10.1021/acschembio.7b0068310.1021/acschembio.7b00683 ↗
83. 10.1126/sciadv.150045410.1126/sciadv.1500454 ↗
84. 10.1073/pnas.180967111510.1073/pnas.1809671115 ↗
85. Yahoo Finance “SQZ Biotechnologies Company (SQZB) ” can be found underhttps://finance.yahoo.com/quote/SQZB/ 2023.
86. 10.1021/acsami.0c1148510.1021/acsami.0c11485 ↗
87. 10.1073/pnas.191712511710.1073/pnas.1917125117 ↗
88. 10.1083/jcb.98.4.155610.1083/jcb.98.4.1556 ↗
89. 10.1242/jcs.102.3.53310.1242/jcs.102.3.533 ↗
90. 10.1089/neu.1997.14.35510.1089/neu.1997.14.355 ↗
91. 10.1002/bit.2165110.1002/bit.21651 ↗
92. Shin H. S. · J. Nanosci. Nanotechnol. · 2009 · 9 · 7330
93. 10.1088/1741-2560/2/4/01110.1088/1741-2560/2/4/011 ↗
94. 10.1038/s41598-018-22042-010.1038/s41598-018-22042-0 ↗
95. 10.1039/b912547g10.1039/b912547g ↗
96. 10.1021/acs.nanolett.3c0172010.1021/acs.nanolett.3c01720 ↗
97. MxT Biotech “MxT Biotech :: Microfluidics x Therapy ” can be found underhttps://mxtbiotech.com/ 2023.
98. Gerhart P. M. · 2016
99. 10.1038/s41598-021-91307-y10.1038/s41598-021-91307-y ↗
100. 10.1002/advs.20200459510.1002/advs.202004595 ↗